Minnesota Oncology Hematology, PA — Saint Paul, Minnesota

Minnesota Oncology Hematology, PA is a clinical research site located in Saint Paul, Minnesota, United States 55102.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

Minnesota Oncology Hematology, PA has participated in 4 clinical trials.

Therapeutic areas: HER2 Positive Breast Cancer, Ovarian Cancer, Non-Small Cell Lung Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, NovoCure Ltd., Astellas Pharma Inc.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Minnesota Oncology Hematology, PA?

Minnesota Oncology Hematology, PA has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Minnesota Oncology Hematology, PA conducted?

Minnesota Oncology Hematology, PA has 4 clinical trials on record. Their work covers HER2 Positive Breast Cancer, Ovarian Cancer, Non-Small Cell Lung Cancer.

Is Minnesota Oncology Hematology, PA accredited by Crixeo Health?

Minnesota Oncology Hematology, PA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Minnesota Oncology Hematology, PA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.